Amicus Therapeutics Inc. (FOLD) Income Statement Analysis - Revenue, Earnings & Profitability Metrics - Stocknear
Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Start Trial

    Amicus Therapeutics Inc.

    NASDAQ: FOLD · Real-Time Price · USD
    8.24
    -0.08 (-0.96%)
    At close: Sep 26, 2025, 3:59 PM
    8.24
    0.00%
    After-hours: Sep 26, 2025, 04:28 PM EDT

    Amicus Therapeutics Income Statement

    Financials in USD. Fiscal year is January - December.

    undefined peaked at n/a in undefined and hit its lowest at n/a in undefined. Over the past five years, it has declined by undefined%.

    Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
    Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
    Revenue
    		 528.29M 399.36M 329.23M 305.51M
    Cost of Revenue
    		 52.94M 37.33M 38.6M 34.47M
    Gross Profit
    		 475.35M 362.03M 290.63M 271.05M
    Operating Income
    		 24.88M -77.21M -204.43M -199.92M
    Interest Income
    		 5.41M 7.08M 3.02M 509K
    Pretax Income
    		 -28.76M -150.1M -242.04M -241.55M
    Net Income
    		 -56.11M -151.58M -236.57M -250.46M
    Selling & General & Admin
    		 323.38M 275.27M 213.04M 192.71M
    Research & Development
    		 109.36M 152.38M 276.68M 272.05M
    Other Expenses
    		 17.73M 11.59M 5.34M 6.21M
    Operating Expenses
    		 450.48M 439.24M 495.06M 470.97M
    Interest Expense
    		 49.6M 50.15M 37.12M 32.47M
    Selling & Marketing Expenses
    		 n/a n/a n/a n/a
    Cost & Expenses
    		 503.42M 476.57M 533.66M 505.43M
    Income Tax Expense
    		 27.35M 1.48M -5.47M 8.91M
    Shares Outstanding (Basic)
    		 304.38M 295.16M 289.06M 271.42M
    Shares Outstanding (Diluted)
    		 304.38M 295.16M 289.06M 271.42M
    EPS (Basic)
    		 -0.18 -0.51 -0.82 -0.92
    EPS (Diluted)
    		 -0.18 -0.51 -0.82 -0.92
    EBITDA
    		 29.39M -92.08M -199.58M -202.87M
    EBIT
    		 20.84M -99.95M -204.92M -209.08M
    Depreciation & Amortization
    		 8.55M 7.87M 5.34M 6.21M

    Add to Watchlist